Prasanna Shirol

AstraZeneca expands its portfolio by bringing rare disease therapy for patients in India

*AstraZeneca completed the acquisition of Alexion in the year 2021 and is now expanding its portfolio globally to bring innovative…

2 years ago

Patient Groups celebrate Dr. Harshvardhan move to expedite the process of rare disease policy formation

New Delhi, June 28, 2019: With the new Government taking the chair, rare disease patients in India see a new…

5 years ago